Advent and Essex Woodlands Exit Biotoscana Via Sale to Knight Therapeutics October 21, 2019 Advent International and Essex Woodlands fully exited Brazilian pharmaceutical company Biotoscana through a strategic sale to Canadian pharmaceutical company Knight Therapeutics. Advent and Essex Woodlands ‘s 51% stake was purchased…